0001683168-24-002942.txt : 20240502
0001683168-24-002942.hdr.sgml : 20240502
20240502202128
ACCESSION NUMBER: 0001683168-24-002942
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240430
FILED AS OF DATE: 20240502
DATE AS OF CHANGE: 20240502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ziebell Mark R
CENTRAL INDEX KEY: 0001552642
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 24910420
MAIL ADDRESS:
STREET 1: 14282 FRANKLIN AVENUE
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-04-30
0
0000704562
Avid Bioservices, Inc.
CDMO
0001552642
Ziebell Mark R
14191 MYFORD ROAD
TUSTIN
CA
92780
0
1
0
0
V. P., General Counsel
0
Common Stock, $0.001 par value
2024-04-30
4
S
0
1643
7.3993
D
64834
D
Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2, 3 and 4 of the reporting person's Form 4 filed with the SEC on April 11, 2024.
Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.33 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Mark R. Ziebell
2024-05-02